The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy
Brodehl A, Gaertner-Rommel A, Klauke B, Grewe SA, Schirmer I, Peterschroeder A, Faber L, Vorgerd M, Gummert J, Anselmetti D, Schulz U, et al. (2017)
HUMAN MUTATION 38(8): 947-952.
Download
No fulltext has been uploaded. References only!
Journal Article
| Original Article
| Published
| English
No fulltext has been uploaded
Author
Brodehl, Andreas
;
Gaertner-Rommel, Anna
;
Klauke, Baerbel
;
Grewe, Simon Andre
;
Schirmer, Ilona
;
Peterschroeder, Andreas
;
Faber, Lothar
;
Vorgerd, Matthias
;
Gummert, Jan
;
Anselmetti, DarioUniBi
;
Schulz, Uwe
;
Paluszkiewicz, Lech
All

All
Abstract
Restrictive cardiomyopathy (RCM) is a rare heart disease characterized by diastolic dysfunction and atrial enlargement. The genetic etiology of RCM is not completely known. We identified by a next-generation sequencing panel the novel CRYAB missense mutation c.326A>G, p.D109G in a small family with RCM in combination with skeletal myopathy with an early onset of the disease. CRYAB encodes B-crystallin, a member of the small heat shock protein family, which is highly expressed in cardiac and skeletal muscle. In addition to in silico prediction analysis, our structural analysis of explanted myocardial tissue of a mutation carrier as well as in vitro cell transfection experiments revealed abnormal protein aggregation of mutant B-crystallin and desmin, supporting the deleterious effect of this novel mutation. In conclusion, CRYAB appears to be a novel RCM gene, which might have relevance for the molecular diagnosis and the genetic counseling of further affected families in the future.
Keywords
Publishing Year
ISSN
eISSN
PUB-ID
Cite this
Brodehl A, Gaertner-Rommel A, Klauke B, et al. The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. HUMAN MUTATION. 2017;38(8):947-952.
Brodehl, A., Gaertner-Rommel, A., Klauke, B., Grewe, S. A., Schirmer, I., Peterschroeder, A., Faber, L., et al. (2017). The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. HUMAN MUTATION, 38(8), 947-952. doi:10.1002/humu.23248
Brodehl, A., Gaertner-Rommel, A., Klauke, B., Grewe, S. A., Schirmer, I., Peterschroeder, A., Faber, L., Vorgerd, M., Gummert, J., Anselmetti, D., et al. (2017). The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. HUMAN MUTATION 38, 947-952.
Brodehl, A., et al., 2017. The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. HUMAN MUTATION, 38(8), p 947-952.
A. Brodehl, et al., “The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy”, HUMAN MUTATION, vol. 38, 2017, pp. 947-952.
Brodehl, A., Gaertner-Rommel, A., Klauke, B., Grewe, S.A., Schirmer, I., Peterschroeder, A., Faber, L., Vorgerd, M., Gummert, J., Anselmetti, D., Schulz, U., Paluszkiewicz, L., Milting, H.: The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. HUMAN MUTATION. 38, 947-952 (2017).
Brodehl, Andreas, Gaertner-Rommel, Anna, Klauke, Baerbel, Grewe, Simon Andre, Schirmer, Ilona, Peterschroeder, Andreas, Faber, Lothar, Vorgerd, Matthias, Gummert, Jan, Anselmetti, Dario, Schulz, Uwe, Paluszkiewicz, Lech, and Milting, Hendrik. “The novel B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy”. HUMAN MUTATION 38.8 (2017): 947-952.
This data publication is cited in the following publications:
This publication cites the following data publications:
1 Citation in Europe PMC
Data provided by Europe PubMed Central.
The role of αB-crystallin in skeletal and cardiac muscle tissues.
Dimauro I, Antonioni A, Mercatelli N, Caporossi D., Cell Stress Chaperones (), 2017
PMID: 29190034
Dimauro I, Antonioni A, Mercatelli N, Caporossi D., Cell Stress Chaperones (), 2017
PMID: 29190034
Export
0 Marked PublicationsWeb of Science
View record in Web of Science®Sources
PMID: 28493373
PubMed | Europe PMC